NEA reprises MGI

New Enterprise Associates is hoping former executives from specialty oncology and acute care company MGI Pharma Inc. can make a repeat performance. The firm is the sole institutional investor in a $20 million series A round disclosed last week in Tesaro Inc., a cancer company led by former MGI management.

NEA reserved another $40 million "to assure they have access to significant capital to move the company forward," general partner David Mott told Ebb & Flow. He added that future rounds would bring in additional investors...